Sponsor:
OHSU Knight Cancer Institute
Code:
NCT06342453
Conditions
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Eligibility Criteria
Sex: All
Age: 8 - 13
Healthy Volunteers: Not accepted
Interventions
Art Therapy
Discussion
Media Intervention
Survey Administration
Brief summary:
Conditions
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Study ID
NCT06342453
Start date
Jun 4, 2024
Status verified date
Aug, 2026
Completion date
Dec 31, 2027
Anticipated
Primary completion date
Dec 31, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 8 - 13
Healthy Volunteers: Not accepted
Enrollment
72 participants
Anticipated
Allocation
Randomized
Intervention Model
Sequential
Primary purpose
Supportive Care
Arms
active comparator: Phase I (focus group)
experimental: Phase II arm I (CrA)
active comparator: Phase II arm II (watch videos)
Interventions
Art Therapy
Discussion
Media Intervention
Survey Administration
Primary outcome measure
Central contacts
Locations
OHSU Knight Cancer Institute
Recruiting
Portland, Oregon, United States, 97239
Contacts
Principal Investigator:
Jennifer L. Raybin
Sponsor
OHSU Knight Cancer Institute
Last update posted
Aug 25, 2026
Last verified
Aug, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by OHSU Knight Cancer Institute on 2026-08-25.